In rats, acute morphine dependence results in antagonist-induced response suppression of intracranial self-stimulationEASTERLING, Keith W; HOLTZMAN, Stephen G.Psychopharmacologia. 2004, Vol 175, Num 3, pp 287-295, issn 0033-3158, 9 p.Article

Effects of cyclazocine on cocaine self-administration in ratsGLICK, S. D; VISKER, K. E; MAISONNEUVE, I. M et al.European journal of pharmacology. 1998, Vol 357, Num 1, pp 9-14, issn 0014-2999Article

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethylcarboxamido] analogues of cyclazocine and ethylketocycalzocineWENTLAND, Mark P; VANALSTINE, Melissa; KUCEJKO, Robert et al.Journal of medicinal chemistry (Print). 2006, Vol 49, Num 18, pp 5635-5639, issn 0022-2623, 5 p.Article

Cyclazocine revisitedARCHER, S; GLICK, S. D; BIDLACK, J. M et al.Neurochemical research. 1996, Vol 21, Num 11, pp 1369-1373, issn 0364-3190Article

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 3: 8-Thiocarboxamido and 8-thioformamido derivatives of cyclazocineWENTLAND, Mark P; XUFENG SUN; YIGONG BU et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 10, pp 2547-2551, issn 0960-894X, 5 p.Article

A laboratory study of hydromorphone and cyclazocine on smoking behavior in residential polydrug usersPICKWORTH, Wallace B; LEE, Eun M; ABREU, Mary E et al.Pharmacology, biochemistry and behavior. 2004, Vol 77, Num 4, pp 711-715, issn 0091-3057, 5 p.Article

Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocinesWENTLAND, Mark P; YINGCHUN YE; BIDLACK, Jean M et al.Journal of medicinal chemistry (Print). 2003, Vol 46, Num 5, pp 838-849, issn 0022-2623, 12 p.Article

(±)Cyclazocine blocks the dopamine response to nicotineMAISONNEUVE, I. M; GLICK, S. D.Neuroreport (Oxford). 1999, Vol 10, Num 4, pp 693-696, issn 0959-4965Article

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: Syntheses and opioid receptor properties of cyclic variants of cyclazocineWENTLAND, Mark P; QUN LU; GANORKAR, Rakesh et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 2, pp 365-368, issn 0960-894X, 4 p.Article

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-Formamidocyclazocine analoguesWENTLAND, Mark P; XUFENG SUN; YINGCHUN YE et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 11, pp 1911-1914, issn 0960-894X, 4 p.Article

8-Carboxamidocyclazocine analogues: Redefining the structure-activity relationships of 2,6-methano-3-benzazocinesWENTLAND, Mark P; RONGLIANG LOU; YINGCHUN YE et al.Bioorganic & medicinal chemistry letters (Print). 2001, Vol 11, Num 5, pp 623-626, issn 0960-894XArticle

Effects of cyclazocine and scopolamine on swim-to-platform performance in ratsBUCKTON, G; ZIBROWSKI, E. M; VANDERWOLF, C. H et al.Brain research. 2001, Vol 922, Num 2, pp 229-233, issn 0006-8993Article